Picture of AtriCure logo

ATRC AtriCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

AtriCure Inc expected to post a loss of 30 cents a share - Earnings Preview

* AtriCure Inc  ATRC.OQ   ATRC.O  is expected to show a rise
in
quarterly revenue when it reports  results on July 25. 
    * The Mason Ohio-based  company is expected to report  a
15.3% increase in revenue to $97.489 million from $84.53 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. The company's guidance on May 2 2023,
for the period ended June 30, was for revenue between $95.36
million and $97.23 million.
    * ​Refinitiv's mean analyst estimate for AtriCure Inc is for
a
loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AtriCure
Inc is
$55​, above​ its last closing price of $54.31. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.34       -0.34      -0.23     Beat    32.1
 Dec. 31 2023  -0.17       -0.18      -0.09     Beat    48.8
 Sep. 30 2022  -0.25       -0.25      -0.27     Missed  -6.8​
 Jun. 30 2022  -0.29       -0.29      -0.32     Missed  -9.3
 ​​Mar.        -0.31       -0.32      -0.33     Missed  -3.2
 31 2022                                                
 Dec. 31 2021  -0.29       -0.29      -0.30     Missed  -3.4​
 Sep. 30 2021  -0.33       -0.32      2.11      Beat    750
 Jun. 30 2021  -0.34       -0.33      -0.36     Missed  -7.5
 This summary was machine generated July 21 at 21:56 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on AtriCure

See all news